Samsung Biologics ranked among the top searched stocks for 14 days in the past month.

As of 9:30 AM on the 22nd, Samsung Biologics is trading at 798,000 KRW, down 0.37% from the previous day. This represents a 30.61% increase compared to May 28. Samsung Biologics is known as the bio business holding company of the Samsung Group.

Over the past five days, individual investors have net purchased 94,623 shares, while foreigners and institutions have net sold 49,994 shares and 46,140 shares, respectively.

On June 15, Samsung Biologics became a market issue with the headline "Record High... Five Consecutive Days of Gains."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing